Baseline characteristics of HIV-negative and HIV-positive women (by group–those starting cART prior to conception and those starting cART after conception).
Sensitivity and secondary analyses for the RRs of neonatal and maternal outcomes associated with exposure to gabapentin compared with unexposed pregnancies after PS adjustment.